TMU Research Center of Urology and Kidney

Medicine & Life Sciences

1. Chronic Renal Insufficiency 100%
2. Taiwan 89%
3. Renal Dialysis 67%
4. Kidney 66%
5. Cohort Studies 45%
6. Dialysis 42%
7. Prostatic Neoplasms 38%
8. Chronic Kidney Failure 36%
9. Meta-Analysis 32%
10. Population 32%
11. Mortality 29%
12. Apoptosis 29%
13. Autophagy 29%
14. Neoplasms 25%
15. Confidence Intervals 24%
16. Therapeutics 24%
17. Reactive Oxygen Species 22%
18. Systematic Reviews 22%
19. Carcinoma 22%
20. Acute Kidney Injury 21%
21. Chronic Obstructive Pulmonary Disease 20%
22. Prostate 19%
23. Serum 19%
24. Odds Ratio 18%
25. Down-Regulation 17%
26. Indican 17%
27. Wounds and Injuries 17%
28. Arsenic 17%
29. Proteins 17%
30. Inflammation 16%
31. Heme Oxygenase-1 16%
32. Urinary Bladder Neoplasms 15%
33. Peritoneal Dialysis 15%
34. Endothelin-1 15%
35. Lung Neoplasms 15%
36. Human Influenza 15%
37. Genes 14%
38. Randomized Controlled Trials 14%
39. Urinary Bladder 14%
40. Databases 14%
41. Peroxisome Proliferator-Activated Receptors 14%
42. Vaccination 13%
43. Androgen Receptors 13%
44. Hypertension 13%
45. Androgens 13%
46. Activating Transcription Factor 3 13%
47. Biomarkers 13%
48. Coronavirus 13%
49. Cardiovascular Diseases 13%
50. urotensin II 12%
51. Castration 12%
52. National Health Programs 12%
53. Fibrosis 12%
54. Up-Regulation 12%
55. Nanoparticles 12%
56. Recurrence 12%
57. Hospitalization 12%
58. Adenocarcinoma of Lung 12%
59. Metabolic Syndrome 12%
60. Congenital bilateral aplasia of vas deferens 11%
61. Heart Failure 11%
62. ErbB Receptors 11%
63. Human Umbilical Vein Endothelial Cells 11%
64. Triple Negative Breast Neoplasms 11%
65. Incidence 11%
66. Gene Expression 11%
67. Neoplasm Metastasis 11%
68. Parathyroid Hormone 11%
69. Propensity Score 11%
70. Air Pollution 11%
71. Endothelial Cells 11%
72. Growth 10%
73. Hydroxymethylglutaryl-CoA Reductase Inhibitors 10%
74. Particulate Matter 10%
75. MicroRNAs 10%
76. In Vitro Techniques 10%
77. Genotype 10%
78. Membranous Glomerulonephritis 10%
79. Survival 10%
80. Safety 10%
81. Extracellular Signal-Regulated MAP Kinases 10%
82. Doxorubicin 9%
83. Interleukin-8 9%
84. Renal Cell Carcinoma 9%
85. Vitamin D 9%
86. Atrial Fibrillation 9%
87. Glomerular Filtration Rate 9%
88. Case-Control Studies 9%
89. Blood Pressure 9%
90. Cell Proliferation 9%
91. Lipopolysaccharides 9%
92. Herniorrhaphy 9%
93. Stroke 9%
94. Angiotensin II 9%
95. Retrospective Studies 9%
96. Phosphorylation 9%
97. Cell Line 9%
98. Oxidative Stress 9%
99. Bone and Bones 8%
100. Type 2 Diabetes Mellitus 8%